PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma
Watcharin Loilome(Khon Kaen University), Puangrat Yongvanit(Khon Kaen University)
Cited by 60
Related Papers
CD44 variant‐dependent redox status regulation in liver fluke‐associated cholangiocarcinoma: A target for cholangiocarcinoma treatment
|Cancer Science|2016|69
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
|Oncology Reports|2016|40
Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial–Mesenchymal Transition Process
|Anticancer Research|2017|24